These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15690540)

  • 1. Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy.
    Sigal SH; Ala A; Ivanov K; Hossain S; Bodian C; Schiano TD; Min AD; Bodenheimer HC; Thung SN
    Liver Transpl; 2005 Jan; 11(1):82-8. PubMed ID: 15690540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume.
    Ke WM; Xie SB; Li XJ; Zhang SQ; Lai J; Ye YN; Gao ZL; Chen PJ
    J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis B core antigen expression pattern predicts response to lamivudine therapy in patients with chronic hepatitis B].
    Shi KD; Hwang SG; Choi JH; Hwang IJ; Yoon JH; Kim KI; Kwon CI; Hong SP; Park PW; Rim KS
    Korean J Hepatol; 2008 Jun; 14(2):197-205. PubMed ID: 18617767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressive features of HBsAg and HBcAg in the livers of chronic hepatitis B and its clinical significance].
    Le XH; Chen XC; Lin Q; Li MZ; Wang M; Liu SY; Yu ZY; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):41-3. PubMed ID: 17429532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
    Zhu R; Huang H; Zhang H; Wang Z; Hu X; Zhai W; Lin Y; Wang J; Zhu H
    Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology.
    Bayram A; Erkilic S; Ozkur A; Bayram M; Sari I
    J Clin Pathol; 2008 Mar; 61(3):338-42. PubMed ID: 17693576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH; Shu X; Chen LB; Huang HH; Zhang K; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis.
    Ma H; Wei L; Guo F; Zhu S; Sun Y; Wang H
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1250-8. PubMed ID: 18624896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment.
    Uzun Y; Bozkaya H; Erden E; Cinar K; Idilman R; Yurdaydin C; Uzunalimoglu O
    J Gastroenterol Hepatol; 2006 Jun; 21(6):977-81. PubMed ID: 16724981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between liver pathological characteristics and serum HBeAg and HBV DNA in 1057 patients with chronic hepatitis B].
    Fan HM; Zhang CL; Ying RS; Chen ZM; Feng QC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):130-2. PubMed ID: 18574537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.
    Mohamadnejad M; Montazeri G; Fazlollahi A; Zamani F; Nasiri J; Nobakht H; Forouzanfar MH; Abedian S; Tavangar SM; Mohamadkhani A; Ghoujeghi F; Estakhri A; Nouri N; Farzadi Z; Najjari A; Malekzadeh R
    Am J Gastroenterol; 2006 Nov; 101(11):2537-45. PubMed ID: 17029616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
    Matthews GV; Cooper DA; Dore GJ
    Antivir Ther; 2007; 12(1):119-22. PubMed ID: 17503756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research of hepatic pathology and clinical characteristics of patients chronic infected with hepatitis B virus in immune tolerant stage].
    You SL; Xing HQ; Liu HL; Rong YH; Zhu B; Xin SJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):374-6. PubMed ID: 18322608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral load speaks little about toll on liver.
    Mahtab MA; Rahman S; Khan M; Kamal M; Mamun AA; Karim MF
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):483-6. PubMed ID: 17897910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.